Where has secondary amyloid gone?
作者信息
Hazenberg B P, van Rijswijk M H
机构信息
Division of Rheumatology Department of Medicine University Hospital Groningen The Netherlands.
出版信息
Ann Rheum Dis. 2000 Aug;59(8):577-9. doi: 10.1136/ard.59.8.577.
Abstract
摘要
相似文献
1
Where has secondary amyloid gone?继发性淀粉样变哪里去了？
Ann Rheum Dis. 2000 Aug;59(8):577-9. doi: 10.1136/ard.59.8.577.
2
[Secondary amyloidosis and Finns].[继发性淀粉样变性与芬兰人]
Duodecim. 1991;107(14):1151-4.
3
Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland.在芬兰，继发性淀粉样变性在炎性关节病患者中的发病率已有所下降。
Clin Rheumatol. 1999;18(2):122-3. doi: 10.1007/s100670050068.
4
[Secondary amyloidosis].
Nihon Rinsho. 1991 Apr;49(4):800-5.
5
Frequency of amyloidosis in Estonian patients with rheumatoid arthritis.爱沙尼亚类风湿性关节炎患者淀粉样变性的发病率
Scand J Rheumatol. 1993;22(5):248-9. doi: 10.3109/03009749309095132.
6
Influence of rheumatoid arthritis on amyloidosis of aging. Comparison of 47 rheumatoid patients with 47 controls matched for age and sex.类风湿关节炎对老年淀粉样变性的影响。47例类风湿患者与47例年龄和性别匹配的对照者的比较。
N Engl J Med. 1971 Sep 2;285(10):534-8. doi: 10.1056/NEJM197109022851002.
7
Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy.类风湿关节炎患者的继发性淀粉样变：胃十二指肠活检的诊断及预后价值
Br J Rheumatol. 1996 Jan;35(1):44-9. doi: 10.1093/rheumatology/35.1.44.
8
A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland.芬兰全国登记处的数据显示，与炎症性风湿性疾病相关的淀粉样变性所致肾脏替代治疗的发病率显著下降。
Amyloid. 2011 Mar;18(1):25-8. doi: 10.3109/13506129.2010.549252. Epub 2011 Feb 1.
9
Prevalence of silent amyloidosis in RA and its clinical significance.类风湿关节炎中无症状淀粉样变性的患病率及其临床意义。
J Rheumatol. 2004 May;31(5):1013-4; author reply 1014.
10
[Amyloidosis in rheumatoid arthritis].
Nihon Rinsho. 1992 Mar;50(3):586-91.
引用本文的文献
1
Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey.土耳其单中心 174 例患者的 AA 淀粉样变性特征和病程：单中心经验。
Rheumatology (Oxford). 2024 Feb 1;63(2):319-328. doi: 10.1093/rheumatology/kead465.
2
Tissue-based diagnosis of systemic amyloidosis: Experience of the informal diagnostic center at Uppsala University Hospital.基于组织的系统性淀粉样变性诊断：乌普萨拉大学医院非正式诊断中心的经验。
Ups J Med Sci. 2022 Sep 27;127. doi: 10.48101/ujms.v127.8913. eCollection 2022.
3
Course and Prognosis of AA Amyloidosis in Patients with Psoriatic Arthritis: Report of Three Cases from a Single Center Cohort and Review of the Literature.银屑病关节炎患者中AA淀粉样变性的病程及预后：单中心队列3例报告并文献复习
Mediterr J Rheumatol. 2022 Jun 30;33(2):185-195. doi: 10.31138/mjr.33.2.185. eCollection 2022 Jun.
4
Immunohistochemical typing of amyloid in fixed paraffin-embedded samples by an automatic procedure: Comparison with immunofluorescence data on fresh-frozen tissue.免疫组化自动检测固定石蜡包埋样本中的淀粉样蛋白：与新鲜冷冻组织免疫荧光数据的比较。
PLoS One. 2021 Aug 24;16(8):e0256306. doi: 10.1371/journal.pone.0256306. eCollection 2021.
5
Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure.载脂蛋白 A-II 通过改变血浆脂蛋白结构诱导急性期反应相关的 AA 淀粉样变性。
Sci Rep. 2018 Apr 4;8(1):5620. doi: 10.1038/s41598-018-23755-y.
6
Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis.类风湿关节炎肺部受累的临床、流行病学和组织病理学特征。
Biomed Res Int. 2017;2017:7915340. doi: 10.1155/2017/7915340. Epub 2017 Nov 7.
7
Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study.接受肿瘤坏死因子抑制剂治疗的继发性淀粉样变性患者的长期随访：一项符合STROBE标准的观察性研究。
Medicine (Baltimore). 2017 Aug;96(34):e7859. doi: 10.1097/MD.0000000000007859.
8
Systemic AA amyloidosis in the red fox (Vulpes vulpes).赤狐（ Vulpes vulpes ）的系统性AA型淀粉样变。
Protein Sci. 2017 Nov;26(11):2312-2318. doi: 10.1002/pro.3264. Epub 2017 Sep 13.
9
Cell-to-cell transfer of SAA1 protein in a cell culture model of systemic AA amyloidosis.在系统性 AA 淀粉样变性的细胞培养模型中 SAA1 蛋白的细胞间转移。
Sci Rep. 2017 Mar 31;7:45683. doi: 10.1038/srep45683.
10
Systemic amyloidosis: a challenge for the rheumatologist.系统性淀粉样变性：风湿科医生面临的挑战。
Nat Rev Rheumatol. 2010 Jul;6(7):417-29. doi: 10.1038/nrrheum.2010.84. Epub 2010 Jun 8.
本文引用的文献
1
The relation between familial Mediterranean fever and amyloidosis.
Curr Opin Rheumatol. 2000 Jan;12(1):61-4. doi: 10.1097/00002281-200001000-00010.
2
Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years.早期“锯齿波”治疗的类风湿关节炎患者在最初8至14年的死亡率。
Scand J Rheumatol. 1999;28(5):282-7. doi: 10.1080/03009749950155463.
3
Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44.穆克-韦尔斯综合征与1号染色体q44区域的基因连锁。
Am J Hum Genet. 1999 Oct;65(4):1054-9. doi: 10.1086/302589.
4
Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland.1989年在芬兰死亡的1666名类风湿性关节炎患者的全国性系列研究中的淀粉样变性。
Rheumatology (Oxford). 1999 Jun;38(6):499-503. doi: 10.1093/rheumatology/38.6.499.
5
Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland.在芬兰，继发性淀粉样变性在炎性关节病患者中的发病率已有所下降。
Clin Rheumatol. 1999;18(2):122-3. doi: 10.1007/s100670050068.
6
A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis.一种检测关节炎患者抽吸脂肪组织中淀粉样蛋白A沉积的定量方法。
Ann Rheum Dis. 1999 Feb;58(2):96-102. doi: 10.1136/ard.58.2.96.
7
SAA1 alleles as risk factors in reactive systemic AA amyloidosis.血清淀粉样蛋白A1（SAA1）等位基因作为反应性系统性AA淀粉样变性的危险因素。
Amyloid. 1998 Dec;5(4):262-5. doi: 10.3109/13506129809007299.
8
Hereditary fevers.遗传性发热
Curr Opin Rheumatol. 1999 Jan;11(1):75-8. doi: 10.1097/00002281-199901000-00013.
9
Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis.158例日本类风湿性关节炎患者的肾脏病理学与用药史分析。
Clin Nephrol. 1998 Sep;50(3):154-60.
10
Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings.类风湿关节炎中的气道受累：临床、功能及高分辨率CT表现
Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1658-65. doi: 10.1164/ajrccm.157.5.9710018.
Zotero 插件